FDA approves new agent for multiple myeloma

MeSH terms

• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Boronic Acids / administration & dosage
• Bortezomib
• Clinical Trials as Topic
• Dexamethasone / administration & dosage
• Disease-Free Survival
• Drug Administration Schedule
• Drug Approval*
• Drug Resistance, Neoplasm / drug effects
• Humans
• Hydroxamic Acids / adverse effects
• Hydroxamic Acids / therapeutic use*
• Indoles / adverse effects
• Indoles / therapeutic use*
• Multiple Myeloma / drug therapy*
• Oligopeptides / administration & dosage
• Panobinostat
• Pyrazines / administration & dosage
• Treatment Outcome
• United States
• United States Food and Drug Administration